Division of Epithelial Biomedicine
Jose L. Jorcano has not added Biography.
If you are Jose L. Jorcano and would like to personalize this page please email our Author Liaison for assistance.
Modulation of cell proliferation by cytokeratins K10 and K16.
Molecular and cellular biology Apr, 1999 | Pubmed ID: 10082575
Skin and hair follicle integrity is crucially dependent on beta 1 integrin expression on keratinocytes.
The EMBO journal Aug, 2000 | Pubmed ID: 10921880
Increased epidermal tumors and increased skin wound healing in transgenic mice overexpressing the catalytic subunit of telomerase, mTERT, in basal keratinocytes.
The EMBO journal Jun, 2001 | Pubmed ID: 11387197
Inhibition of protein kinase B (PKB) and PKCzeta mediates keratin K10-induced cell cycle arrest.
Molecular and cellular biology Nov, 2001 | Pubmed ID: 11585925
Functional roles of Akt signaling in mouse skin tumorigenesis.
Oncogene Jan, 2002 | Pubmed ID: 11791176
Analysis of the ultraviolet B response in primary human keratinocytes using oligonucleotide microarrays.
Proceedings of the National Academy of Sciences of the United States of America Mar, 2002 | Pubmed ID: 11867738
The expression of keratin k10 in the basal layer of the epidermis inhibits cell proliferation and prevents skin tumorigenesis.
The Journal of biological chemistry May, 2002 | Pubmed ID: 11889133
Severe abnormalities in the oral mucosa induced by suprabasal expression of epidermal keratin K10 in transgenic mice.
The Journal of biological chemistry Sep, 2002 | Pubmed ID: 12119299
Beyond structure: do intermediate filaments modulate cell signalling?
BioEssays : news and reviews in molecular, cellular and developmental biology Sep, 2002 | Pubmed ID: 12210520
Impaired NF-kappa B activation and increased production of tumor necrosis factor alpha in transgenic mice expressing keratin K10 in the basal layer of the epidermis.
The Journal of biological chemistry Apr, 2003 | Pubmed ID: 12566451
Abnormal epidermal differentiation and impaired epithelial-mesenchymal tissue interactions in mice lacking the retinoblastoma relatives p107 and p130.
Development (Cambridge, England) Jun, 2003 | Pubmed ID: 12702649
Modulation of the angiogenesis response through Ha-ras control, placenta growth factor, and angiopoietin expression in mouse skin carcinogenesis.
Molecular carcinogenesis Jun, 2003 | Pubmed ID: 12766907
A keratin K5Cre transgenic line appropriate for tissue-specific or generalized Cre-mediated recombination.
Genesis (New York, N.Y. : 2000) May, 2004 | Pubmed ID: 15124227
Inhibition of xenografted human melanoma growth and prevention of metastasis development by dual antiangiogenic/antitumor activities of pigment epithelium-derived factor.
Cancer research Aug, 2004 | Pubmed ID: 15313901
Epidermal abnormalities and increased malignancy of skin tumors in human epidermal keratin 8-expressing transgenic mice.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology Oct, 2004 | Pubmed ID: 15319370
Long-term engraftment of single genetically modified human epidermal holoclones enables safety pre-assessment of cutaneous gene therapy.
Molecular therapy : the journal of the American Society of Gene Therapy Sep, 2007 | Pubmed ID: 17579576
Modeling normal and pathological processes through skin tissue engineering.
Molecular carcinogenesis Aug, 2007 | Pubmed ID: 17610222
IKKalpha enhances human keratinocyte differentiation and determines the histological variant of epidermal squamous cell carcinomas.
Cell cycle (Georgetown, Tex.) Jul, 2008 | Pubmed ID: 18604171
IKKbeta leads to an inflammatory skin disease resembling interface dermatitis.
The Journal of investigative dermatology Jun, 2010 | Pubmed ID: 20200541
Increased IKKα expression in the basal layer of the epidermis of transgenic mice enhances the malignant potential of skin tumors.
PloS one , 2011 | Pubmed ID: 21755017
Tumor initiation by skin Ha-ras-ment.
Experimental dermatology Apr, 2015 | Pubmed ID: 25607847
1Department of Bioengineering and Aerospace Engineering, Universidad Carlos III de Madrid (UC3M),
2Group of Optics, Photonics and Biophotonics (GOFB). Center for Biomedical Technology, Universidad Politécnica de Madrid,
3Division of Epithelial Biomedicine, CIEMAT,
4, Instituto de Investigación Sanitaria Gregorio Marañón
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved